Blood pressure changes after intravenous fosphenytoin and levetiracetam in patients with acute cerebral symptoms

Epilepsy Research

Volumn 87, Issue 2-3, 2009, Pages 268-271

  Kassab, Mounzer Y ^a   Lobeck, Inna N ^b   Majid, Arshad ^a   Xie, Yan ^c   Farooq, Muhammad U ^a  

^a Michigan State University and Sparrow Health System   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Fosphenytoin; Hypotension; Intravenous load; Levetiracetam; Seizure prophylaxis

Indexed keywords

ETIRACETAM; FOSPHENYTOIN SODIUM;

ACUTE BRAIN DISEASE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEIZURE; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPOTENSION; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT SELECTION; PHENYTOIN; PIRACETAM; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 70449670309     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.09.016     Document Type: Article

References (13)

1. Adams B.D., Buckley N.H., Kim J.Y., and Tipps L.B. Fosphenytoin may cause hemodynamically unstable bradydysrhythmias. J. Emerg. Med. 30 1 (2006) 75-79
2. Browne T.R., Kugler A.R., and Eldon M.A. Pharmacology and pharmacokinetics of fosphenytoin. Neurology 46 6 Suppl. 1 (1996) S3-S7
3. Chesnut R.M., Marshall S.B., Piek J., Blunt B.A., Klauber M.R., and Marshall L.F. Early and late systemic hypotension as a frequent and fundamental source of cerebral ischemia following severe brain injury in the Traumatic Coma Data Bank. Acta Neurochir. Suppl. (Wien) 59 (1993) 121-125
4. Eldon M.A., Loewen G.R., and Voightman R.E. Pharmacokinetics and tolerance of fosphenytoin and phenytoin administration intravenously to healthy subjects. Can. J. Neurol. Sci. 20 (1993) 5180
5. Farooq M.U., Naravetla B., Majid A., Gupta R., Pysh J.J., and Kassab M.Y. IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit. Care 7 1 (2007) 36-39
6. Knake S., Hamer H.M., and Rosenow F. Status epilepticus-a critical review. Epilepsy Behav. February (2009)
7. Kokoska E.R., Smith G.S., Pittman T., and Weber T.R. Early hypotension worsens neurological outcome in pediatric patients with moderately severe head trauma. J. Pediatr. Surg. 33 2 (1998) 333-338
8. Levy R.H., Ragueneau-Majlessi I., and Baltes E. Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers. Epilepsy Res. 46 2 (2001) 93-99
9. Nicolas J.M., Collart P., Gerin B., Mather G., Trager W., Levy R., and Roba J. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Drug Metab. Dispos. 27 2 (1999) 250-254
10. Oliveira-Filho J., Silva S.C., Trabuco C.C., Pedreira B.B., Sousa E.U., and Bacellar A. Detrimental effect of blood pressure reduction in the first 24 h of acute stroke onset. Neurology 61 8 (2003) 1047-1051
11. Patsalos P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol. Ther. 85 2 (2000) 77-85
12. Ramsay R.E., and DeToledo J. Intravenous administration of fosphenytoin: options for the management of seizures. Neurology 46 6 Suppl. 1 (1996) S17-S19
13. Winchell R.J., Simons R.K., and Hoyt D.B. Transient systolic hypotension. A serious problem in the management of head injury. Arch. Surg. 131 5 (1996) 533-539